Multicenter study to evaluate paxalisib plus gemcitabine for children and young adults with recurrent or progressive AT/RT, where no approved therapies currently exist SYDNEY, Sept....
The new Energizer 3-in-1 Child Shield™ features the exclusive new colour alert technology, child-resistant packaging, and a non-toxic bitter coating to...
SUZHOU, China, April 9, 2025 /PRNewswire/ -- BaseCare Medical, a trailblazer in reproductive health and China's first publicly traded company in the assisted reproductive...
LONDON, MONTREAL, and OSLO, Norway, April 9, 2025 /PRNewswire/ -- Sandbrook Capital, a private investment firm focused on building leading climate infrastructure companies, and...